A Randomized Phase 2 Study of Trastuzumab and Pertuzumab (TP) Compared to Cetuximab and Irinotecan (CETIRI) in Advanced/metastatic Colorectal Cancer (mcrc) with HER2 Amplification: SWOG S1613.
Journal of Clinical Oncology(2023)
AI Read Science
Must-Reading Tree
Example

Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined